Genetic Testing and Screening in Medullary Thyroid Cancer

Nearly a quarter of patients with medullary thyroid cancer have a hereditary version of the disease that is related to MEN 2A, MEN 2B, or a familial MTC syndrome. In this segment, panelists explore the proper approaches to genetic testing and screening for these hereditary syndromes.

This segment includes perspectives from moderator, Ezra Cohen, MD, and Steven I. Sherman, MD, R. Michael Tuttle, MD, and Lori J. Wirth, MD.

For more from this discussion, visit http://www.onclive.com/peer-exchange/managing-mtc